Has Stan Golin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,925 in general payments to Stan Golin, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stan Golin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stan Golin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stan Golin, MD

Radiation Oncology · New Hyde Park, NYNPI 1942281035

Payments from drug & device makers

$8,925in general payments, 2019–2025

Across 42 payments — averaging $212.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bioprotect Medical, Inc.$7K
Blue Earth Diagnostics$1K
Teleflex LLC$182
Palette Life Sciences, Inc.$180
Myovant Sciences Inc.$129
Isoray, Inc$86
plus $375 from 8 others

What the payments were for

Consulting fees$1,10012%
Travel & lodging$5,81765%
Food & beverage$2,00822%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bioprotect Medical, Inc.	17	$6,667
Blue Earth Diagnostics	9	$1,306
Teleflex LLC	1	$182
Palette Life Sciences, Inc.	1	$180
Myovant Sciences Inc.	2	$129
Isoray, Inc	1	$86
Astellas Pharma US Inc	1	$78
Accuray Incorporated	1	$62
Bayer	3	$54
Bard Peripheral Vascular, Inc.	2	$44
Boston Scientific	1	$38
Dendreon Pharmaceuticals LLC	1	$37
Myriad Genetic Laboratories, Inc.	1	$36
Progenics Pharmaceuticals, Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,925 in reported general payments places this provider in the 80th percentile of 397 radiation oncology providers in New York.

See all radiation oncology providers in New York →

Medicare billing

Part B allowed, 2024

$2,546,932

Medicare patients

342

Services billed

9,048

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in New Hyde Park

Vishesh AgrawalNew Hyde Park$16K
Narek ShaverdianNew York$9.8M
Timothy ChanNew York$3.8M
Chung ChungSyracuse$3.1M
Brandon ImberNew York$2.8M
Silvia FormentiNew York$2.7M
Steven FinkelsteinSyracuse$2.6M
Christopher BarkerNew York$2.5M
Chandan GuhaBronx$1.6M
Michael ZelefskyNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →